LEUCOVORIN CALCIUM PENTAHYDRATE

PRODUCT IDENTIFICATION

CAS NO. 1492-18-8

LEUCOVORIN CALCIUM

EINECS NO. 216-082-8
FORMULA C20H21N7O7·Ca· 5H2O
MOL WT. 601.58

H.S. CODE

 

TOXICITY

 
SMILES

 

SYNONYMS Calcium folinate; 5-HCO-H4PteGlu; Calcium Leucovorin;
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid, Calcium salt; Citrovorum factor; Folinic acid, calcium salt; Leucosar; Leucovorin Citrovorum; N-(4-(((2-Amino-5-formyl- 1,4,5,6,7,8- hexahydro-4-oxo-6-pteridinyl)methyl) amino)benzoyl)-L- glutamic acid, calcium salt; N-(p-(((2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl) methyl)amino)benzoyl) glutamic acid, calcium salt; Folinato calcico; Folinate de calcium;

CLASSIFICATION

 

PHYSICAL AND CHEMICAL PROPERTIES

PHYSICAL STATE yellow crystalline powder
MELTING POINT  
BOILING POINT  
SPECIFIC GRAVITY  
SOLUBILITY IN WATER  
pH  
VAPOR DENSITY

 

AUTOIGNITION

 

NFPA RATINGS

 

REFRACTIVE INDEX

 
FLASH POINT

 

STABILITY Stable under ordinary conditions. Hygroscopic, light sensitive.

APPLICATIONS

Folinic acid, chemically reduced derivative of folic acid (5-formyl-5,6,7,8-tetrahydrofolate), acts as a coenzyme carrier in certain folate-mediated reactions but does not require dihydrofolate reductase activity. Thus, it is used as a calcium salt to counteract the toxic effects of folic acid antagonists (e.g., methotrexate) and for treatment of megaloblastic anemias; administered intramuscularly. Leucovorin is also used in combination with fluorouracil to treat cancer of the colon. The chemical designation is N-(4-(((2-Amino-5-formyl-1,4,5,6, 7,8- hexahydro- 4-oxo-6- pteridinyl) methyl) amino) benzoyl)-L-glutamic acid, calcium salt (1:1).
SALES SPECIFICATION (USP24)

APPEARANCE

yellow crystalline powder

IDENTIFICATION

Complies

ASSAY

95.0% - 105.0%

WATER

17.0% max

HEAVY METALS

10ppm max

TRANSPORTATION
PACKING

 

HAZARD CLASS  
UN NO.  
OTHER INFORMATION
Hazard Symbols: XN, Risk Phrases: 36/37/38-42/43, Safety Phrases: 26-36